Men who are carriers of BRCA2 mutations are at higher risk of developing prostate cancer than non-carriers, and when they are diagnosed with prostate cancer, it tends to be with higher grade, more aggressive disease (4–6). This evidence concerns the gene BRCA2 and prostate cancer.